Novartis AG (NVS) Ownership
NVS ownership summary
as of October 18, 2026- Institutions
- 7.3% of shares outstanding
- Insiders
- 0.01% of shares outstanding
- Shares outstanding
- 1.90B
- Float
- 1.86B shares available to trade
- Short interest
- 0.30% 5.6M shares short
- Days to cover
- 2.15 short interest down 0.0% vs prior month
- Institutions 7.26%
- Insiders 0.01%
- Other investors 92.73%
NVS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 0.82% | 15.5M | $2.34B | +1.6M (+11.8%) | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | 0.46% | 8.7M | $1.31B | +199,790 (+2.3%) | June 30, 2026 |
| 3 | Dimensional Fund Advisors, Inc. | 0.43% | 8.1M | $1.22B | +7,470 (+0.1%) | June 30, 2026 |
| 4 | PRIMECAP Management Company | 0.35% | 6.6M | $992.9M | −975,230 (−12.9%) | June 30, 2026 |
| 5 | Loomis, Sayles & Company LP | 0.28% | 5.2M | $789.1M | −186,791 (−3.4%) | June 30, 2026 |
| 6 | Bank of America Corp | 0.26% | 4.9M | $739.5M | −52,856 (−1.1%) | June 30, 2026 |
| 7 | Franklin Templeton Inc | 0.17% | 3.3M | $489.7M | −158,663 (−4.7%) | June 30, 2026 |
| 8 | BlackRock Inc | 0.16% | 3.0M | $459.1M | +98,228 (+3.3%) | June 30, 2026 |
| 9 | The Goldman Sachs Group Inc | 0.16% | 3.0M | $448.9M | −3.5M (−54.3%) | June 30, 2026 |
| 10 | Northern Trust Corp | 0.15% | 2.8M | $420.6M | +6,517 (+0.2%) | June 30, 2026 |
| 11 | Natixis Advisors, LLC. | 0.13% | 2.4M | $359.5M | +150,371 (+6.7%) | June 30, 2026 |
| 12 | HHG PLC | 0.12% | 2.3M | $342.8M | +41,520 (+1.9%) | March 31, 2026 |
| 13 | JPMorgan Chase & Co | 0.12% | 2.3M | $341.1M | +459,771 (+25.5%) | June 30, 2026 |
| 14 | Jupiter Topco LLC | 0.12% | 2.2M | $334.6M | +2.2M (0.0%) | June 30, 2026 |
| 15 | GQG Partners LLC | 0.11% | 2.2M | $324.0M | −296,141 (−12.1%) | June 30, 2026 |
| 16 | FMR Inc | 0.11% | 2.1M | $309.9M | +364,411 (+21.5%) | June 30, 2026 |
| 17 | Cullen Capital Management, LLC | 0.11% | 2.0M | $306.2M | −4,922 (−0.2%) | June 30, 2026 |
| 18 | JONES FINANCIAL COMPANIES LLLP | 0.10% | 2.0M | $297.3M | +152,247 (+8.4%) | June 30, 2026 |
| 19 | WCM Investment Management | 0.10% | 1.9M | $286.8M | +441,169 (+30.2%) | June 30, 2026 |
| 20 | Wells Fargo & Co | 0.10% | 1.8M | $275.5M | −66,860 (−3.5%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 5.8M shares and 8 cut 5.3M.
NVS top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard PRIMECAP Inv | 0.22% | 4.3M | $640.6M | −947,300 (−18.2%) | June 30, 2026 |
| 2 | MUAM Foreign Equity Index Mother | 0.11% | 2.1M | $313.0M | +2.1M (0.0%) | May 20, 2026 |
| 3 | DFA International Core Equity 2 I | 0.10% | 1.9M | $285.8M | −81,190 (−4.1%) | August 31, 2026 |
| 4 | Loomis Sayles Growth Y | 0.07% | 1.3M | $202.5M | −28,944 (−2.1%) | August 31, 2026 |
| 5 | Vanguard Capital Opportunity Inv | 0.06% | 1.2M | $182.4M | — | June 30, 2026 |
| 6 | Janus Henderson Global Life Sciences D | 0.06% | 1.1M | $165.8M | +70,319 (+6.8%) | August 31, 2026 |
| 7 | Janus Henderson Glb Life Scn I2 USD | 0.06% | 1.1M | $159.0M | +160,492 (+17.9%) | August 31, 2026 |
| 8 | Janus Global Life Science AUSD | 0.05% | 895K | $134.8M | +10,939 (+1.2%) | June 30, 2026 |
| 9 | Principal Equity Income A | 0.05% | 892K | $134.4M | −17,733 (−1.9%) | September 30, 2026 |
| 10 | Dimensional International Value ETF | 0.05% | 889K | $133.9M | — | September 30, 2026 |
| 11 | Franklin Mutual Shares Z | 0.04% | 800K | $120.6M | −12,122 (−1.5%) | August 31, 2026 |
| 12 | Dimensional International Cr Eq Mkt ETF | 0.04% | 776K | $116.9M | — | September 30, 2026 |
| 13 | Dimensional International Core Eq 2 ETF | 0.04% | 721K | $108.6M | +88 (+0.0%) | September 30, 2026 |
| 14 | Vanguard PRIMECAP Core Inv | 0.04% | 670K | $100.9M | — | June 30, 2026 |
| 15 | Lord Abbett Affiliated A | 0.04% | 668K | $100.6M | — | August 31, 2026 |
| 16 | Avantis International Equity ETF | 0.04% | 667K | $100.5M | — | September 30, 2026 |
| 17 | Dimensional International High Pbly ETF | 0.03% | 588K | $88.6M | — | September 30, 2026 |
| 18 | GQG Partners US Select Quality Eq Instl | 0.03% | 565K | $85.1M | −102,504 (−15.4%) | June 30, 2026 |
| 19 | Dimensional World ex US Core Eq 2 ETF | 0.03% | 518K | $78.0M | — | September 30, 2026 |
| 20 | Loomis Sayles US Growth Eq I/A USD | 0.03% | 483K | $72.7M | +19,665 (+4.2%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NVS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NVS
Institutional investors own 7.3% of Novartis's shares and insiders 0.01%. The largest holder is Fisher Asset Management, LLC with 0.82% of the shares (15.5M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 0.30% of the float, or 2.15 days of average trading volume. The share count fell 21.2% since 2014.
Related: NVS analyst forecast, NVS key metrics, NVS dividend history. See the NVS stock overview for the latest quote and news.
NVS ownership FAQ
Who owns the most Novartis stock?
The largest shareholders of Novartis are Fisher Asset Management, LLC (0.82%), Morgan Stanley - Brokerage Accounts (0.46%), Dimensional Fund Advisors, Inc. (0.43%), PRIMECAP Management Company (0.35%), Loomis, Sayles & Company LP (0.28%).
What percentage of Novartis is owned by institutions?
Institutions hold 7.3% of Novartis's shares outstanding; insiders hold 0.01%.
Which funds own Novartis?
The largest fund holders of Novartis are Vanguard PRIMECAP Inv (0.22%), MUAM Foreign Equity Index Mother (0.11%), DFA International Core Equity 2 I (0.10%), Loomis Sayles Growth Y (0.07%), Vanguard Capital Opportunity Inv (0.06%).
What is Novartis's short interest?
5.6M shares of Novartis were sold short, 0.30% of the float; at the average daily volume it would take 2.15 days to cover.
How many shares of Novartis are outstanding?
Novartis has 1.90B shares outstanding, of which 1.86B are in the public float.